Director/PDMR Shareholding

RNS Number : 5054H

MyHealthChecked PLC

24 November 2022

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

MyHealthChecked PLC

( " MyHealthChecked " or the "Company " )

Director/PDMR Dealing

MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that Nicholas Edwards, Chief Financial Officer of the Company, purchased 125,000 Ordinary Shares of 0.1p each in the Company ("Ordinary Shares") at a price of 1.849p per Ordinary share (the "Purchase"). Following the Purchase, Nicholas Edwards has a beneficial interest of 125,000 Ordinary Shares, representing 0.016 per cent. of the total issued share capital.

In addition, Lesley Innes, Non-Executive Director, purchased 250,000 Ordinary Shares of 0.1p each at a price of 1.835p per Ordinary Share. Following the Purchase, Lesley Innes has a beneficial interest of 250,000 Ordinary Shares, representing 0.032 per cent. of the total issued share capital.

For further information contact:

MyHealthChecked plc		www.myhealthchecked.com
P enny McCormick, Chief Executive Officer		via Walbrook PR
Nicholas Edwards, Chief Financial Officer
SPARK Advisory Partners Limited (NOMAD)		Tel: [phone]
Neil Baldwin
Oberon Capital Ltd (Broker)		Tel: [phone]
Mike Seabrook		[e-mail]
Walbrook PR Ltd (Media & IR)	Tel: [phone] or [e-mail]
Anna Dunphy		Mob: [phone]

About MyHealthChecked PLC ( www.myhealthcheckedplc.com )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests , supported by a user-friendly digital interface. .

MyHealthChecked is the umbrella brand of a range of at-home wellness tests that are available online, and will be viable for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

Notification   and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Nicholas Edwards
2	Reason for the notification
a)	Position/status	Chief Financial Officer
b)	Initial notification/amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MyHealthChecked PLC
b)	LEI	213800RBHY6LZDG13168
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.1p each
	Identification code	GB00BYZ2R301
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
			Price(s)	Volume (s)
			1.849p	125,000
d)	Aggregated information
	- Aggregated volume	N/A - Single transaction
	- Price
e)	Date of the transaction	24 November 2022
f)	Place of the transaction	AIM, London Stock Exchange (XLON)

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Lesley Innes
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification/amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MyHealthChecked PLC
b)	LEI	213800RBHY6LZDG13168
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary shares of 0.1p each
	Identification code	GB00BYZ2R301
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)
			Price(s)	Volume(s)
			1.835p	250,000
d)	Aggregated information
	- Aggregated volume	N/A - Single transaction
	- Price
e)	Date of the transaction	24 November 2022
f)	Place of the transaction	AIM, London Stock Exchange (XLON)

 

END

 

 

DSHBZLFLLFLXFBE